NewsPositive | October 17, 2026 | Health
Some of the most meaningful advances in healthcare happen quietly. They begin with a child receiving a vaccine, a healthcare worker helping a family, or a community making preventive care part of everyday life.
On October 12, 2026, the World Health Organization announced that Albania and Armenia had met its regional hepatitis B control targets. The achievement follows more than two decades of vaccination programmes designed to protect children from a potentially serious liver infection.
A generation growing up with greater protection
Hepatitis B is a viral infection that affects the liver. Some infections become chronic, raising the risk of cirrhosis and liver cancer later in life. Because the virus can pass from mother to child around birth, early prevention matters greatly.
National surveys in Albania and Armenia found no hepatitis B surface-antigen-positive results among the children aged six to eight who were tested. Those results helped support WHO’s validation that both countries had met regional control targets.
The survey findings do not establish that no child anywhere in the two countries has hepatitis B. They are nevertheless meaningful evidence of strong protection in the sampled age groups.
Why prevention at birth matters
WHO recommends a first hepatitis B vaccine dose as soon as possible after birth, ideally within 24 hours, followed by the rest of the schedule. Maternal screening and appropriate care also help reduce transmission.
The benefits of successful prevention are often invisible: infections that never occur and people who may avoid serious health problems decades later.
An achievement recognised by experts
The European Technical Advisory Group of Experts on Immunization reviewed the evidence and validated the countries’ progress against regional targets. WHO reported a recognition ceremony in Armenia on October 6, 2026.
Both countries join others in the WHO European Region that have reached control milestones. Their progress contributes to the larger goal of eliminating viral hepatitis as a public-health threat.
The people behind the progress
Years of effective vaccination depend on healthcare workers delivering doses reliably, health authorities monitoring programmes and families having access to preventive care.
Such work seldom makes dramatic headlines. Yet consistent prevention can change the prospects of a generation.
Control does not mean eradication
The WHO recognition does not mean hepatitis B has disappeared. Adults may still live with chronic infections, and vaccination, screening and treatment remain necessary.
Nor does a survey with no detected infections prove prevalence is exactly zero across the wider population. Sustained surveillance and access to prevention remain essential.
The quiet power of prevention
For families, successful public health means fewer risks and healthier futures. Albania and Armenia’s milestone shows what patient, sustained work can achieve.
Sometimes the most encouraging health stories are not about diseases that have been cured. They are about diseases that children may never have to experience.
Sources and verification
Good things are happening. We’re here to find them.
